News & Press Releases

Imagine the public outcry if a fully loaded Airbus crashed, and the corporation, the pilots and the FAA all knew about the technical flaw that brought that plane down, but did nothing to stop it. Now, imagine if an event like that happened every single day. This is the magnitude of patient-adverse events that occur in this country every year due to patient misidentification. Annually, over 114K patients die in the U.S. due to wrong patient errors.This startling statistic has been cited by multiple reports and agencies devoted to patient safety and designs around promoting an accurate patient identity experience.

But still - healthcare providers go to work every day without total confidence that the patient they are providing services for is, in fact, the person they believe them to be. Patient misidentification may be inadvertent (ex: two patients with the same name and same DOB have their clinical records overlaid within the hospital’s EMR system) or it may be intentional (a person steals the identity of another patient and passes them self off as that individual to receive care). Of course, not all misidentification events result in an adverse event. Most are caught in a timely fashion before any harm is done, while some mistakes may result in incorrect billing or insurance filing. But, no matter the underlying cause or the severity of the outcome, the fact remains that hundreds of patients each day come close to harm or death, and don’t even know it.

This paper describes the current thinking around patient identity and designs to replace a broken process with one that seems to be “good enough”. We propose that there is a better way that has been in place for many years and has been used successfully by other industry sectors. There is a solution that is ready for deployment today and will have an immediate impact on patient safety.

Ingenico announces their continuation of growth in the healthcare industry with an advanced point of sale payment platform that integrates LifeMed ID's patient identity solution, AIMe. The unification of solutions will simplify the collection process, improve patient engagement, accelerate the speed of service, and improve payment security across the continuum of care.

Shanghai, China and MINNEAPOLIS June 28, 2017 (OTCIQ) -- Sage Convalescence Gaiety (“SCG”) a, Shanghai, China healthcare firm and OrangeHook, Inc. (OTCQB: ORHK) (“OrangeHook”), announced today that they have reached an agreement on material terms and executed a non-binding term sheet to form a joint venture based in Shanghai for the delivery of healthcare infrastructure solutions in the China healthcare market. The joint venture’s intended product offerings will be based on each of the parties’ proprietary technologies, and will include an SCG integrated “continuum of care” platform powered by OrangeHook’s patient identification and payments technologies. The to-be-named JV intends to offer bundled healthcare technology services to Chinese healthcare providers consisting of point of sale hardware solutions, state of the art smart cards, and mobile SIM card applications.

“We expect China’s healthcare providers and consumers will significantly benefit from OrangeHook’s solution offerings,” said Xian Feng, Chairman & CEO of SCG. “These high-performance systems are intended to reduce patient identification errors and related fraud issues, which has the potential to vastly reduce liabilities for Chinese healthcare providers and significantly improve patient care. These applications identify the patient with high reliability, creating interoperability efficiencies for China’s healthcare system and the 1.4 billion Chinese citizens who attend China’s healthcare facilities on average 5.5 times per year.”

“Our intended partnership and joint solution is truly driven by customer demand in the China market,” James L. Mandel, CEO of OrangeHook, Inc. stated. “Healthcare providers desire flexibility and performance quality, which are offered by the OrangeHook applications, as well as the superior data efficiency, mobility, and built-in data protection that is compliant with all healthcare standards, which we believe only OrangeHook solutions deliver. OrangeHook is excited about this planned relationship with SCG and the proven experience and background of the SCG management team.”

A key component of the term sheet calls for SCG to purchase between 500,000 and 2 million shares of OrangeHook’s common stock and/or payment of royalties depending on the timing and amount of the stock purchase. All equity purchases are to be based upon a valuation of a minimum of $20 per share. Closing of the transaction is subject to conditions including, among other things, completion of definitive agreements, board approvals, and possible regulatory approvals by both the United States and Chinese governments. Additional details of the transaction will be disclosed once a definitive agreement is executed.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that represent OrangeHook management’s expectations or beliefs about future events relating to its planned joint venture with SCG. Forward-looking statements are identifiable by words such as “believe”, “intend”, “anticipate”, “expect”, “plan”, “will”, “may”, and other similar expressions. Forward-looking statements made in this press release, which relate to OrangeHook’s proposed agreement and planned joint venture with SCG, involve known and unknown risks and uncertainties that may cause the actual results to differ materially from those expected and stated in this announcement. Actual results could differ if the Chinese economy, and particularly the healthcare segments of the Chinese economy that impact the proposed JV’s business, does not grow and perform at least as well as forecast. In addition, actual results could differ as a result of, among other things, (i) the parties’ inability to reach a definitive agreement based on the term sheet, (ii) a failure of any closing condition in the definitive agreement to occur or be waived, (iii) a lack of market acceptance for the JV’s product offerings or any inability or undue delay in bringing those product offerings to market, (iv) any non-compliance or inability to comply with Chinese corporate or healthcare laws or U.S. laws governing foreign investment or foreign business practices and (iv) any inability on the part of either party to continue to finance the JV or its own operations. It is not possible to foresee or identify all factors that could cause actual results to differ from expected results. As such, you should not consider any list of such factors to be an exhaustive statement of all risks, uncertainties or potential inaccurate assumptions nor should you place undue reliance on any forward-looking statements contained in this press release. For additional information on factors that could cause our actual results to differ and for more specific information about our business and the risks associated with it, please review the periodic reports that OrangeHook files publicly with the Securities and Exchange Commission. Forward-looking statements made herein speak only as to the date of this press release and, except as expressly required by the securities laws, we undertake no obligation to publicly update any forward-looking statements made herein.

Contacts:

OrangeHook, Inc.
James Mandel, CEO
This email address is being protected from spambots. You need JavaScript enabled to view it.

On June 15, 2017, an article was released titled "Solving the unsolvable: 3 reasons hospitals should adopt a unique health safety identifier". The article outlines the importance of implementing a unique health safety identifier for value-based care and patient safety, and supports their claims by featuring LifeMed ID's client, Tahoe Forest.

LifeMed ID’s valued partner LenovoHealth is conducting a 3-day conference called the Virtual Innovation Summit which is taking place from June 6th-8th, 2017. The theme of the virtual conference focuses on innovation strategies for customized care anywhere. Day 2 (June 7th) is focused on AIMe: Protecting Patient ID & Data Access Across the Continuum of Care. For a preview on topics that were addressed during the summit, please reference interview that Becker’s Health conducted with LenovoHealth's Director, Global Health Solution Strategy, Tom Foley.

On May 15, 2017, an article was released titled "Search and Rescue Teams Sharpen Skills During Weekend Exercise in Dalmeny". This article outlines how the Salamander solutions aided Search and Rescue Saskatchewn Association of Volunteers (SARSAV), along with RCMP and Dalmeny Police Service officers, track movement and radio transmissions of registered search personnel in real time.

Starting on April 7th, 2017, Salamander Technologies and the Long Beach Fire Department assisted with the 2017 Toyota Grand Prix held in Long Beach, California. Measures were taken to ensure the safety and accountability of the individuals working and volunteering for the event.

MINNEAPOLIS, March 14, 2017 (GLOBE NEWSWIRE) -- Through a recently signed Agreement between Medsis, a U.S. based big data company, and the Colombian Government’s National Victims Repair Unit, an initiative was launched to modernize the entire Colombian citizens database system by means of the donation of Medsis’ big data management technology platform, CEREBRO, and OrangeHook resources. The system will convert all existing databases into a single unified civil registry. The use of CEREBRO, along with advanced state-of-the-art security protocols and algorithms, will allow identities of all registered victims to be safely verified and stored, creating efficiencies in all programs within the National Victims Repair Unit and potentially beyond. The National Victims Repair Unit was created to facilitate reparation payments which are a key component of the Colombian Government’s recent peace agreement with the FARC in their efforts to achieve a conclusion of the country’s 60-year-old internal conflict.

The project will provide a platform for the distribution of benefits to more than 8 million identified victims. Under terms of the agreement payments of approximately 1.2 Trillion Colombian Pesos ($400 Million USD) will be distributed annually over the next ten years, over 12 trillion pesos ($4B USD) in total.

WAIV, an Australian company focused on payment applications, will be the financial bridge between the National Victims Repair Unit and the persons registered in it. Together with a known payment network for the WAIVCARD and the participation of a Colombian bank, WAIV will be responsible for integrating the MEDSIS: CEREBRO platform to accurately disburse the reparations and financial humanitarian aid to the people registered in the database. The integration with WAIV as a processor makes possible the accurate and timely procedure to manage and disburse the funds to the victims over the next 10 years.

DAX CABRERA, President and CEO of Medsis stated, “This historic project, to help heal the nation of Colombia, is exactly what Medsis was designed for. The vision of Colombia and of director ALAN JARA to provide humanitarian aid throughout Colombia, is an important global goal of Medsis.”

John Fenga, CEO of WAIV, expressed his satisfaction at being part of this initiative that will allow relief to victims of Colombia's unfortunate internal conflict, “We’re excited to be a part of this incredible opportunity,” said Fenga, “Helping the less fortunate is a key part of the WAIV philosophy.”

OrangeHook, a Minneapolis, Minnesota-based company, is an identification authentication company with systems and applications focused in healthcare, government, and data transfer accuracy.

James Mandel, OrangeHook CEO, stated, “We are delighted to be recognized as a leader in identification processes, and look forward to our continuing involvement in this historic program.”

For more information about OrangeHook, please visit www.orangehook.com.

About the players:

The Victims Unit (UnidadVictimas.gov.co) is a branch of the Colombian Government whose objective is to help and integrally repair the victims of war, with the objective of completing social inclusion and reparation of all affected victims.

Medsis (Medsis.com) is an international information technology company that provides platforms for data management, integration, consolidation, and analysis. Their systems are designed to operate in environments with volatile infrastructure such as remote, rural, and conflict areas.

WAIV (WAIVCard.com) is an international technology company offering a comprehensive payment system designed to make banking online safer, faster, and cheaper. Its aim is to increase global financial inclusion for the 2 billion unbanked people worldwide.

OrangeHook (orangehook.com) (OTC:NUVLD) is a global leader in identity solutions. Through its suite of proprietary technologies, OrangeHook helps health, government, and corporate entities with cloud-based validation, accreditation, and verification services.

Contacts:

OrangeHook, Inc.
James Mandel, CEO
This email address is being protected from spambots. You need JavaScript enabled to view it.

Medsis
Sara Cabrera
This email address is being protected from spambots. You need JavaScript enabled to view it.

WAIV
John Fenga, CEO
This email address is being protected from spambots. You need JavaScript enabled to view it.

Morganton, NC — MARCH 7, 2017- Effective Monday, March 13, Rob DeVaun will assume the position of North American Sales Director for Salamander Technologies, an OrangeHook Company. DeVaun has worked as Technical Sales Consultant and Salamander Specialist for Bridgeway Solutions for the last few years advancing the Salamander footprint across the Southeast.
While Bridgeway Solutions is losing a key sales representative, DeVaun will continue his long-standing commitment to emergency management, incident command and the implementation of Salamander’s Intelligent Accountability™ suite across the U.S. He will maintain a supportive role for individual agencies and regions using the Solution, and will assist in the direction of sales and implementation within each territory.

“Rob isn’t really leaving us. As Adam Fray’s successor at Salamander Technologies, he will be tasked with helping us continue building upon the successes he, himself, helped drive in the Southeast over the past few years,” said David Lee, General Manager, Bridgeway Solutions. “His dedication, resourcefulness and work ethic will serve him well as he begins the next chapter of his career.”

“We are excited to be a part of Rob’s next chapter. Not only does Rob bring experience and success in managing state wide solutions, but he has the expertise to drive continued success with our channel partners,” said Robert F. Riess, COO/CMO - OrangeHook, Inc. “The additional support that Bridgeway has provided with this transition, in conjunction with Rob’s accomplishments, shows how dedicated our partners are to the solutions which Salamander provides”.

DeVaun joined Bridgeway Solutions in the fall of 2014 and quickly became the company’s driving force for the Salamander Solutions within the region. From DPRs in North Carolina, to state-wide adoption in South Carolina, and rapidly increasing adoption in Georgia and Virginia, DeVaun has worked closely with agencies large and small to find funding resources and implement the powerful incident command solution.

As of 2017, over 17,000 agencies have access to Salamander’s TAG, TRACK and REPORT Solution. From rescue efforts for Hurricane Matthew, to security personnel management for sporting events like the U.S. Open, the Salamander Solution has proven to be invaluable, with enabled real-time tracking of resources. Salamander’s latest editions allow responders to check-in as they are in route to an incident, commanders to know exactly who is on-scene and what their qualifications are, and when all is safely secured, to enable comprehensive reporting for maximum reimbursement from FEMA and other support agencies.

For additional information on Salamander Technologies visit www.salamanderlive.com or BridgewayID.com/salamander.html. To arrange a webinar or demo, contact Rob DeVaun at 919-616-7495.

At the Hospital Council of Northern and Central California’s recent 2016 Summit in Napa, CA, Tahoe Forest Health System (TFHS), a LifeMed ID client, won the Innovation Challenge for its new Blue Life wellness program.Read more

Lenovo Health, a progressive leader in health IT, announces its partnership with LifeMed ID, Inc. to bring a solution to the industry that addresses duplicate records, medical identity theft, and payment fraud.Read more

-Upon completion, combined company will be an SEC reporting, publicly traded and fully integrated SaaS-based conglomerate of disruptive technology solutions centered on healthcare, big data, safety, and banking-Transaction designed to establish public company platform that adds the OrangeHook suite of product and service offerings to Nuvel’s existing operations, substantially reduce Nuvel’s existing debt and preserve value opportunity for existing Nuvel shareholders

LOS GATOS, Calif. and MINNEAPOLIS, July 13, 2016 (GLOBE NEWSWIRE) -- Nuvel Holdings, Inc. (OTC PINK:NUVL) has entered into a definitive merger agreement with OrangeHook, Inc., of Minneapolis, Minnesota, a privately-held Software as a Service (SaaS) conglomerate. Upon closing of the transaction, the combined company will be fully reporting and publicly-traded and will consist of five operating entities that use complementary proprietary technology to offer disruptive and potentially life-changing applications centered on healthcare, big-data, safety and banking.

The material terms of the agreement are summarized in a Current Report on Form 8-K of Nuvel filed with the Securities and Exchange Commission on Friday, July 8, 2016. In the transaction, Nuvel will issue shares of two new classes of preferred stock to OrangeHook shareholders in exchange for all of OrangeHook’s preferred and common stock. Following the merger, Nuvel will effect a reverse split of its common stock, after which the preferred shares issued in the merger to OrangeHook’s common shareholders will convert into one share of common stock in the combined company for each share of OrangeHook common stock held immediately prior to the merger, and a substantial majority of Nuvel’s existing debt will be exchanged for equity in the combined company.

The existing shareholders of Nuvel will have the opportunity to participate in ongoing growth opportunities in the combined company. Such shareholders who hold Nuvel common stock immediately after closing of the merger (or a record date declared shortly thereafter), will be eligible to receive up to an aggregate of 357,143 shares of Nuvel common stock on a pro-rata basis if the Nuvel, Inc. operating entity achieves a $1.5 million revenue milestone, as measured and within the timeframes specified in the agreement. Based on current projections, management of the combined company is optimistic about the achievement of the earn-out milestone.

For purposes of structuring the transaction, the parties used an assumed $14 per share valuation for OrangeHook’s common stock, which is the same valuation that OrangeHook used to structure the prior acquisitions of its other portfolio companies. Based on the assumed $14 per share valuation of OrangeHook common stock, the value of these prior transactions totaled approximately $53.2 million. This assumed valuation of OrangeHook common stock was arbitrarily determined based upon pro-forma financial projections of OrangeHook management and there exists no quantifiable valuation analysis to support the same, aside from internal projections based upon existing contracts of the combined companies, among other factors.

Following the merger, the combined company will change its name to OrangeHook and plans to trade under a yet to be determined OrangeHook-related trading symbol. The combined company will immediately encompass the expanded offerings of the OrangeHook portfolio within the newly formed and recapitalized company. Subsequent to the merger, the combined company plans to apply for listing on a national securities exchange as soon as reasonably practical.

Rick Resnick, Nuvel’s CEO, commented, “This transaction allows Nuvel to more freely move forward as a result of the elimination of the vast majority of our current debt, which we believe positions the company for substantial growth and stability. We believe the transaction offers a fair exchange for existing Nuvel common shareholders through the participation in a future earn-out distribution based on a revenue milestone we are confident of achieving.”

James Mandel, OrangeHook CEO, commented, “We are very pleased to achieve the next step in our company’s evolution, which sets the stage for the public launch of our suite of disruptive and potentially life-changing applications designed to change the world we live in for the better in areas including mobile payments, healthcare information, billing and payments, data compression and storage, and emergency responder coordination. Although we acknowledge that we are setting a high bar with our operating goals, we strongly believe that customer acceptance of our solutions and the real world need for the same will validate our optimism. We expect the coordinated and sophisticated deployment of our product and service offerings will create substantial value for existing OrangeHook and Nuvel shareholders, as well as future investors.”

Subject to satisfaction or waiver of closing conditions set forth in the merger agreement, the parties expect to close on the merger portion of the transaction in August 2016 and to effect the post-merger reverse split recapitalization to be completed by approximately Labor Day.

About Nuvel

Nuvel Holdings, Inc. seeks to engage in the business of designing, developing and selling a family of proxy and other appliances, and related software and services that secure, accelerate and optimize the delivery of business applications, Web content and other information to distributed users over private Enterprise networks, or across an enterprise's gateway to the public Internet.

About OrangeHook

OrangeHook is a holding company that accelerates the growth of selective and unique consumer, business, and governmental software applications which have the ability, in our opinion, to change the world we live in to be a better and safer place concentrating in the fields of safety, medicine, data acceleration, and banking. More at http://www.orangehook.com.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for certain forward-looking statements. Certain statements in this press release, including statements regarding the proposed merger between OrangeHook and Nuvel, the anticipated recapitalization, the value proposition of the transaction for existing Nuvel shareholders, targeted future revenue amounts for Nuvel, Inc. and operating results for the combined company, the anticipated completion dates for the merger and reverse split, and the assumed valuation for OrangeHook common stock (and the corresponding aggregate value of OrangeHook’s prior acquisitions), are forward-looking in nature. These statements are based on current expectations and intentions, as well as assumptions and estimates that management believed to be credible and reasonable but that are also subject to risks and uncertainties that may cause outcomes to differ from what is expected, including risks that the merger will not close in a timely manner or at all, or that the combined companies’ operating results will not meet management’s expectations.

For additional information regarding this transaction please contact the following:

Wayzata, MN. Thought leaders across the technology economy take note: a new player is in town. OrangeHook, Inc., a technology holding company focused upon turbocharging disruptive software solutions, brings a wide breadth of industry and management experience, as well as an array of diverse backgrounds and cultural insights to bear on a market that is traditionally defined by its intensive specialization.

Allowing subject matter experts from a myriad of different backgrounds to work cohesively, interweaving years of experience, the latest technological breakthroughs and a solid foundation of analytical data leads OrangeHook to have a uniquely effective multifaceted approach to managing its holdings. Combining experts in the healthcare, network optimization, financial services and emergency management fields with decades of proven business leadership experience, OrangeHook’s hybrid approach to leadership highlights opportunities and synergies that otherwise would have gone unrecognized.

“We accept and appreciate a wide variety of different cultures,” says James Mandel, Chief Executive Officer of OrangeHook, Inc. “Not only do we accept and appreciate differences in ethnicity, race, age, sexual orientation, gender and religion, but we also greatly appreciate the beliefs, attitudes, values, life experiences and unique interests shared by our colleagues in the technology industry. By encouraging this type of diversity and seeking varied inputs, we are able to see a wide array of viewpoints and can utilize that awareness to create novel solutions and build bridges across seemingly insurmountable gaps, all while maximizing the resultant positive effects on the bottom line.”

Investors and business owners interested in learning more about OrangeHook and its portfolio companies are invited to visit our website at orangehook.com.

About OrangeHook, Inc.
OrangeHook, Inc. is a holding company focusing on companies with SaaS solutions that need additional assistance to impact the world today. Through its portfolio companies, OrangeHook accelerates a selective collection of consumer, business, and governmental software applications which meet the primary criteria of “changing the world we live in to be a better and safer place.” More at http://www.orangehook.com.

In the GAO Congressional Report released April 24th, 2015, LifeMed ID is named “electronically readable card vendor” and their client, Resolute Health (Tenet), is named the “health care provider that has issued electronically readable cards to patients.”Read more

The National Association of Healthcare Access Management (NAHAM) has partnered with LifeMed ID to develop a Continuing Education Training Module to educate NAHAM’s members, and non-members across the nation, on patient ID authentication.Read more